603998.SS

Hunan Fangsheng Pharmaceutical Co., Ltd. [603998.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

603998.SS Stock Summary

In the News

603998.SS Financial details

Company Rating
Strong Buy
Market Cap
4.05B
Income
177.64M
Revenue
1.65B
Book val./share
3.25
Cash/share
0.49
Dividend
0.35
Dividend %
3.21%
Employees
1.6K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2023
P/E
26.88
Forward P/E
-
PEG
1.7
P/S
3
P/B
3.36
P/C
19.31
P/FCF
-37.93
Quick Ratio
0.67
Current Ratio
1
Debt / Equity
0.49
LT Debt / Equity
0.2
-
-
EPS (TTM)
0.41
EPS next Y
-
EPS next Q
-
EPS this Y
312.5%
EPS next Y
-
EPS next 5Y
30.75%
EPS last 5Y
31.17%
Revenue last 5Y
11.26%
Revenue Q/Q
-14.04%
EPS Q/Q
-19.3%
-
-
-
-
SMA20
-18.37%
SMA50
-20.83%
SMA100
-4.29%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
13%
ROC
0.11%
Gross Margin
69%
Oper. Margin
13%
Profit Margin
11%
Payout
99%
Shs Outstand
428.42M
Shs Float
256.67M
-
-
-
-
Target Price
-
52W Range
7.12-14.73
52W High
-32.43%
52W Low
+35.14%
RSI
48.71
Rel Volume
0.63
Avg Volume
7.54M
Volume
4.74M
Perf Week
15.23%
Perf Month
-17.52%
Perf Quarter
-
Perf Half Y
6.89%
-
-
-
-
Beta
0.355
-
-
Volatility
0.35%, 1.04%
Prev Close
0.21%
Price
9.46
Change
0.64%

603998.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.452.633.013.584.14
Net income per share
0.170.190.150.160.66
Operating cash flow per share
0.410.390.560.420.7
Free cash flow per share
0.24-0.090.1600.3
Cash per share
0.610.380.750.631.02
Book value per share
2.452.712.712.733.21
Tangible book value per share
1.971.71.851.542.28
Share holders equity per share
2.452.712.712.733.21
Interest debt per share
0.430.761.071.261.28
Market cap
1.95B3.45B2.55B2.98B3.47B
Enterprise value
1.81B3.6B2.67B3.25B3.6B
P/E ratio
26.6543.6839.9342.512.14
Price to sales ratio
1.853.151.991.91.94
POCF ratio
11.0521.210.7616.0411.5
PFCF ratio
19.23-93.4936.973.25K26.61
P/B Ratio
1.853.062.212.492.5
PTB ratio
1.853.062.212.492.5
EV to sales
1.723.292.092.072.01
Enterprise value over EBITDA
12.1620.9915.3615.937.95
EV to operating cash flow
10.2622.1211.2717.5111.93
EV to free cash flow
17.86-97.5638.723.55K27.6
Earnings yield
0.040.020.030.020.08
Free cash flow yield
0.05-0.010.0300.04
Debt to equity
0.170.270.380.450.38
Debt to assets
0.110.150.20.20.18
Net debt to EBITDA
-0.930.870.691.340.29
Current ratio
1.490.940.910.691.19
Interest coverage
16.818.916.135.4214.46
Income quality
2.212.064.42.651.09
Dividend Yield
00.010.030.020.04
Payout ratio
0.130.331.070.670.43
Sales general and administrative to revenue
0.010.020.020.020.02
Research and developement to revenue
0.040.040.040.030.04
Intangibles to total assets
0.160.250.210.230.18
Capex to operating cash flow
-0.43-1.23-0.71-1-0.57
Capex to revenue
-0.07-0.18-0.13-0.12-0.1
Capex to depreciation
-1.7-3.71-2.38-2.36-2.19
Stock based compensation to revenue
00000
Graham number
3.063.413.023.146.9
ROIC
0.060.060.050.040.15
Return on tangible assets
0.050.050.040.030.12
Graham Net
-0.08-0.88-0.86-1.74-1.17
Working capital
229.59M-44.2M-80.85M-388.83M191.5M
Tangible asset value
844.13M707.76M787.79M674.96M987.8M
Net current asset value
169.59M-147.56M-181.36M-534.2M-223.11M
Invested capital
0.170.270.380.450.38
Average receivables
189.76M205.08M236.87M280.93M368.07M
Average payables
46.07M71.59M99.19M110.34M141.39M
Average inventory
182.54M199.59M208.14M233.25M280.06M
Days sales outstanding
64.4574.9471.1272.8486.25
Days payables outstanding
64.61115.5981.4775.93103.1
Days of inventory on hand
257.68251.62165.12166.36188.88
Receivables turnover
5.664.875.135.014.23
Payables turnover
5.653.164.484.813.54
Inventory turnover
1.421.452.212.191.93
ROE
0.070.070.060.060.21
Capex per share
-0.17-0.48-0.39-0.42-0.4

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.1311.030.980.82
Net income per share
0.460.080.150.10.08
Operating cash flow per share
0.460.080.1500
Free cash flow per share
0.36-0.020.02-0.13-0.17
Cash per share
0.641.020.570.50.49
Book value per share
3.173.213.433.283.25
Tangible book value per share
2.332.282.452.332.36
Share holders equity per share
3.173.213.433.283.25
Interest debt per share
1.141.231.141.461.61
Market cap
2.6B3.47B5.18B5.36B4.83B
Enterprise value
2.84B3.6B5.46B5.78B5.33B
P/E ratio
3.3124.3420.3231.2334.2
Price to sales ratio
5.367.9911.8712.8113.42
POCF ratio
13.2397.3481.2700
PFCF ratio
16.8-441.57622.07-96.22-64.27
P/B Ratio
1.912.53.553.843.39
PTB ratio
1.912.53.553.843.39
EV to sales
5.878.2912.513.8214.83
Enterprise value over EBITDA
12.9147.9677.06101.67124.18
EV to operating cash flow
14.49100.9985.5700
EV to free cash flow
18.4-458.1655.03-103.79-71.02
Earnings yield
0.080.010.010.010.01
Free cash flow yield
0.0600-0.01-0.02
Debt to equity
0.360.380.330.440.49
Debt to assets
0.190.180.160.20.22
Net debt to EBITDA
1.121.733.887.4111.8
Current ratio
1.071.191.181.051
Interest coverage
26.9718.3821.619.676.38
Income quality
11100
Dividend Yield
0.02000.020.01
Payout ratio
0.260.450.062.771.05
Sales general and administrative to revenue
0.18-0.170.08-0.030.24
Research and developement to revenue
0.030.050.040.050.06
Intangibles to total assets
0.20.180.180.180.17
Capex to operating cash flow
-0.21-1.22-0.8700
Capex to revenue
-0.09-0.1-0.13-0.13-0.21
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
5.712.443.42.732.43
ROIC
0.10.020.030.020.02
Return on tangible assets
0.10.010.030.020.01
Graham Net
-0.97-1.17-1.41-1.68-1.67
Working capital
55.77M191.5M171.1M49.37M-2.68M
Tangible asset value
1B987.8M1.04B989.3M1.03B
Net current asset value
-179.5M-223.11M-268.77M-376.17M-396.92M
Invested capital
0.360.380.330.440.49
Average receivables
342.13M361.54M463.47M521.2M544.08M
Average payables
144.75M142.51M206.85M254.35M252.87M
Average inventory
293.83M296.06M325.12M356.93M369.52M
Days sales outstanding
55.6887.74103.75115.91137.43
Days payables outstanding
68.92106.47158.61191.12197.81
Days of inventory on hand
166.64195.05221.74269.17300.2
Receivables turnover
1.621.030.870.780.65
Payables turnover
1.310.850.570.470.45
Inventory turnover
0.540.460.410.330.3
ROE
0.140.030.040.030.02
Capex per share
-0.1-0.1-0.13-0.13-0.17

603998.SS Frequently Asked Questions

What is Hunan Fangsheng Pharmaceutical Co., Ltd. stock symbol ?

Hunan Fangsheng Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 603998.SS

What is Hunan Fangsheng Pharmaceutical Co., Ltd. stock quote today ?

Hunan Fangsheng Pharmaceutical Co., Ltd. stock price is $9.46 today.

Is Hunan Fangsheng Pharmaceutical Co., Ltd. stock public?

Yes, Hunan Fangsheng Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Similar Market Cap